← Eichor
Condition: Cholestatic Liver Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cholestatic Liver Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT06825559
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT05045482
Vitamin D2 vs Vitamin D2 Plus Calcitriol in Cholestatic Children With Vitamin D Deficiency
Phase 4 · 1 location(s) · Chulalongkorn University · NCT07670611
DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE
NA · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07317193
Biobank for Cholestatic Liver Diseases.
Phase N/A · 1 location(s) · Mayo Clinic · NCT03445585
DILIN - Prospective Study
Phase N/A · 6 location(s) · Duke University · NCT00345930
Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)
Phase N/A · 1 location(s) · Asociación Española para el Estudio del Hígado · NCT06767605
China Registry for Genetic / Metabolic Liver Diseases
Phase N/A · 12 location(s) · Beijing Friendship Hospital · NCT03131427
Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis
Phase N/A · 2 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06781242
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Pr
Phase 2 · 130 location(s) · Mirum Pharmaceuticals, Inc. · NCT05050136
Drug-Induced Liver Injury (DILI) Network Retrospective
Phase N/A · 6 location(s) · Duke University · NCT00360646
Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers
Phase N/A · 5 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06777914
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.